Abstract
Integrins are adhesion receptors that connect cells to components of the extracellular matrix or to counter receptors on other cells. Besides mediating stable adhesion, these receptors are implicated in the deposition of extracellular matrices and they are crucial for cell migration. Integrin-mediated adhesion also modulates signal transduction cascades downstream of other receptors and thereby regulates cell survival, proliferation, and the expression of differentiation-related genes. In this review, an overview of the evidence for roles of integrins in tissue development and function is given and the contribution of changes in integrin expression to cancer is discussed.
Keywords: drosophila melanogaster, extracellular, matrix, arg-gly-asp
Current Pharmaceutical Design
Title: Integrins: Regulators of Tissue Function and Cancer Progression
Volume: 11 Issue: 7
Author(s): Erik H.J. Danen
Affiliation:
Keywords: drosophila melanogaster, extracellular, matrix, arg-gly-asp
Abstract: Integrins are adhesion receptors that connect cells to components of the extracellular matrix or to counter receptors on other cells. Besides mediating stable adhesion, these receptors are implicated in the deposition of extracellular matrices and they are crucial for cell migration. Integrin-mediated adhesion also modulates signal transduction cascades downstream of other receptors and thereby regulates cell survival, proliferation, and the expression of differentiation-related genes. In this review, an overview of the evidence for roles of integrins in tissue development and function is given and the contribution of changes in integrin expression to cancer is discussed.
Export Options
About this article
Cite this article as:
Danen H.J. Erik, Integrins: Regulators of Tissue Function and Cancer Progression, Current Pharmaceutical Design 2005; 11 (7) . https://dx.doi.org/10.2174/1381612053381756
DOI https://dx.doi.org/10.2174/1381612053381756 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
From Body Art to Anticancer Activities: Perspectives on Medicinal Properties of Henna
Current Drug Targets Anticancer Effects of Ginsenoside Rh2: A Systematic Review
Current Molecular Pharmacology TGF-β Signaling in Gastrointestinal Cancer Stem Cells
Current Cancer Therapy Reviews Unfoldomics of Human Genetic Diseases: Illustrative Examples of Ordered and Intrinsically Disordered Members of the Human Diseasome
Protein & Peptide Letters Role of mTOR in Hematological Malignancies
Current Cancer Therapy Reviews Cell Cycle as a Target of Antineoplastic Drugs
Current Pharmaceutical Design The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents RING Finger E3 Ubiquitin Ligases: Structure and Drug Discovery
Current Pharmaceutical Design The Mechanism of Calcitriol in Cancer Prevention and Treatment
Current Medicinal Chemistry VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Current Cancer Drug Targets Peptide Aptamers: Specific Inhibitors of Protein Function
Current Molecular Medicine Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside
Current Pharmaceutical Design AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives
Current Drug Targets Advances in the Development of Non-Human Viral DNA-Vectors for Gene Delivery
Current Gene Therapy Genome and Transcriptome Analysis of Neuroblastoma Advanced Diagnosis from Innovative Therapies
Current Pharmaceutical Design Linking Inflammation to Cell Cycle Progression
Current Pharmaceutical Design Stem Cells as Vectors to Deliver HSV/tk Gene Therapy for Malignant Gliomas
Current Stem Cell Research & Therapy Sphingolipid Signaling and Hematopoietic Malignancies: To the Rheostat and Beyond
Anti-Cancer Agents in Medicinal Chemistry Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers
Current Medicinal Chemistry An Overview of Nanoformulated Nutraceuticals and their Therapeutic Approaches
Current Nutrition & Food Science